Cryoballoon Ablation for Early Persistent Atrial Fibrillation (Cryo4 Persistent AF)
Cryoballoon Ablation for Early Persistent Atrial Fibrillation
Sponsor: Medtronic Cardiac Ablation Solutions
A NA clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by Medtronic Cardiac Ablation Solutions and has accumulated 9 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Mar 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Mar 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
Nov 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Nov 2017 [monthly]
Active Not Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Ablation Solutions
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Athens, Greece , Bad Oeynhausen, Germany , Berlin, Germany , Cologne, Germany , Créteil, France , Frankfurt, Germany , Grenoble, France , Hamburg, Germany , Marseille, France , Nuremberg, Germany and 3 more locations